Search Results 181-190 of 35953 for Two-phase
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
One full cycle of IVF takes about 2 to 3 weeks. Sometimes these steps are split into different parts and the process can take longer. In vitro fertilization is ...
... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...
... phase II dose (RP2D of APG2575 in combination ... Patients will be randomized 1:1 into the two arms. ... 2-6: 500 mg/m2). Patients randomized to B+R will ...
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer. Participation eligibility. Participant eligibility ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...
The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your World Cancer Day gift can go 2X as far.